In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab’s (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD. He discusses the science behind the MedTech technology; the progress toward obtaining FDA approval; and, the real potential to develop screening for further neurological conditions. Professor Wang also highlights the strategic collaborations with other prestigious academic institutions.
More From The Market Online
Aussie XTX slammed as fresh tech worries spurt on Wall Street. OpenAI’s IPO will be next big indicator
In case you haven’t noticed what with gold and silver going crazy, the Australian XTX technology index had an extremely poor day all
- Jonathon Davidson
- 3 mins
- 04 February 2026 16:25 (AEDT)
Carnavale Resources kicks off Kookynie BFS drilling
Carnavale Resources has begun an H1CY26 drilling program to support the bankable feasibility study (BFS) at…
- Colin Sandell-Hay
- 2 mins
- 04 February 2026 16:22 (AEDT)
Terrain Minerals set for Lightning strike; will explore Wildflower at the same time
Terrain Minerals (ASX: TMX) is preparing to test two prospects at the Smokebush Project in Western…
- Colin Sandell-Hay
- 2 mins
- 04 February 2026 15:26 (AEDT)
The ASX Today: We’re only halfway through this insane week; gold back over US$5K/oz; tech index beheaded
Greetings and welcome to ASX Today for Wednesday of Week 6, Iām Jon Davidson.
- Jonathon Davidson
- 3 mins
- 04 February 2026 15:22 (AEDT)
